Diagnostics; making a difference

Member Press Releases

Current Articles | Categories | Search | Syndication

30 July 2015  Joanne Hunter
Ultra Sensitive Protein Detection Technology Showcased at Alzheimer’s Conference with identification of new biomarkers for early stage diagnosis and monitoring of this disease.
By Joanne Hunter @ 13:48 :: 8 Views

Cobham, UK – 30th July, 2015. Proteome Sciences plc (‘Proteome Sciences’) gave three oral presentations at last  week’s Alzheimer’s Association International Conference, 2015 (AAIC), highlighting how its proprietary TMTcalibrator™ and SysQuant® technologies are finding proteins undetectable by other methodologies.

Read More

27 July 2015  Joanne Hunter
New bench-top clinical chemistry analyzer launched by EKF Diagnostics at AACC 2015
By Joanne Hunter @ 11:27 :: 16 Views

Cardiff, UK – 23rd July 2015 – EKF Diagnostics, the global in vitro diagnostics company, announces the international launch of the Altair™ 240 clinical chemistry analyzer at the American Association for Clinical Chemistry’s (AACC) Annual Meeting and Clinical Lab Expo in Atlanta, Ga, 26-30 July. This new bench-top platform represents EKF Diagnostics’ first fully integrated chemistry system designed for the global market. Also on Booth #1018, EKF will highlight the latest additions to its range of Stanbio liquid-stable, LiquiColor® and Liqui-UV® clinical chemistry reagents.

Read More

27 July 2015  Joanne Hunter
FABPulous wins €1.6m EU grant for clinical trials of 5 minute heart attack test
By Joanne Hunter @ 10:12 :: 15 Views

July 20th 2015, Maastricht (Netherlands) - The European Union awarded FABPulous BV a 1.6 million Phase 2 grant to fund two clinical trials in the UK and Belgium/Netherlands and automate the manufacture of its 5 minute, patented H-FABP True Rapid Test, which helps emergency medical workers quickly distinguish whether a patient with chest pain is at risk of a heart attack.

Read More

21 July 2015  Rebecca Bellars
Cytox and Affymetrix form strategic partnership to develop and commercialize blood-based genetic assay for Alzheimer’s disease risk assessmen
By Rebecca Bellars @ 16:03 :: 48 Views

20 July 2015: Oxford, UK. Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational research and diagnostic solutions, announce a strategic partnership where the two companies are to collaborate on developing and commercializing a blood-based genetic assay for research in diagnosis and prognosis of Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI).

Read More

17 July 2015  Joanne Hunter
EKF Diagnostics’ Growth Drives New Role Creation
By Joanne Hunter @ 08:56 :: 48 Views

Expanding business welcomes new faces to further strengthen IVD expertise and new product development.

Read More

09 July 2015  Joanne Hunter
IBDoc® - Supporting New Standards of Care for IBD The first CE marked Calprotectin Home Test
By Joanne Hunter @ 12:14 :: 56 Views

Managing chronic conditions such as diabetes and hypertension through patient self-testing has become common place. It is now also possible for sufferers of inflammatory bowel disease (IBD) to manage their condition from home. The new BÜHLMANN IBDoc® system, now available from Alpha Laboratories, utilises sophisticated technology that enables IBD patients to perform quantitative faecal calprotectin testing themselves, in just three easy steps, reading the results using their smartphones.

Read More

09 July 2015  Joanne Hunter
Proteome Sciences to deliver ground-breaking programmes with CK1d, SysQuant® & TMTcalibrator™ at AAIC 2015.
By Joanne Hunter @ 10:09 :: 67 Views

Cobham, UK – July 8th, 2015. Proteome Sciences plc (‘Proteome Sciences’) will present news and results across different aspects of its Alzheimer’s research programmes at the upcoming Alzheimer’s Association International Conference® 2015 (AAIC®) taking place in Washington, D.C., USA from 18-23 July, 2015.

Read More

29 June 2015  Joanne Hunter
BBI Group develops rapid test to aid identification and potentially help minimise spread of Ebola virus
By Joanne Hunter @ 16:05 :: 85 Views

29th June 2015 – CARDIFF, U.K. – The BBI Group (BBI) today announced it has developed in collaboration with the Defence Science and Technology Laboratory (Dstl) and licensed, through technology transfer company Ploughshare Innovations, a rapid test for Ebola. The assay, which is in the process of being verified to allow EUA submission, will be used to test patients suspected of Ebola infection to screen and potentially help with how they are subsequently managed. The test, utilising lateral flow technology, can provide a result in approximately 20 minutes.

Read More

24 June 2015  Joanne Hunter
Publication of Annual Report
By Joanne Hunter @ 11:47 :: 102 Views

The Company announces that its Annual Report and Accounts for the year ended 31 December 2014, together with a notice of the Annual General Meeting and accompanying form of proxy, are available to view on the Company’s website at www.proteomics.com, and will be posted to
shareholders imminently.

Read More

24 June 2015  Joanne Hunter
Placing to raise £2.5 million
By Joanne Hunter @ 10:45 :: 171 Views

23 June 2015: Proteome Sciences plc (AIM:PRM) ("Proteome Sciences" or the "Company") is pleased to announce it has conditionally raised approximately £2.5 million, before expenses, through the placing of 13,861,112 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares" and the "Placing Shares") at a price of 18 pence per Ordinary Share (the "Placing Price" and the "Placing").

Read More

Previous Page | Next Page